Nocion Therapeutics
ID: 5837413Nocion Therapeutics is developing positively charged versions of "caines" -- broadly acting intracellular sodium channel blockers
2
Funding Rounds
$54.0m
Money raised
Recent Funding Rounds
Overview
Nocion Therapeutics is developing positively charged versions of "caines" -- broadly acting intracellular sodium channel blockers
- Website:
- Business model: B2B
- Social accounts: linkedin
Unlock Complete Company Intelligence
Access comprehensive data and insights available only to Seedtable members
Financial Details
- • Complete funding history and valuations
- • Revenue estimates and financial metrics
- • Investment round details and terms
People & Contacts
- • Complete leadership team profiles
- • Contact information and email addresses
- • Board members and advisors
Market Intelligence
- • Competitive landscape analysis
- • Market position and growth metrics
- • Industry benchmarking data
Premium Tools
- • Export data and generate reports
- • Save companies to custom watchlists
- • API access for data integration
Join 10,000+ Professionals
Trusted by investors, founders, and analysts worldwide
Access detailed insights on 71,000+ companies worldwide
| Name | Phone | Social networks | |
|---|---|---|---|
| Br*** Be** | - | - | - |
| Cl****** J. Wo*** | - | - | - |
| Br*** Le** | - | - | - |
Funding series
Funding Series Analysis
The company Nocion Therapeutics has raised a total of $27m in funding over 2 rounds.
Key Insights:
- Nocion Therapeutics Series A round, April 2019: $27m
- Nocion Therapeutics funding round, April 2019: $27m
Industries
Nocion Therapeutics is active in the following industries: